Susceptibility of escherichia coli strains isolated from urine cultures to some commonly used antibacterial agents

dc.contributor.authorYulugkural, Zerrin
dc.contributor.authorMutlu, Birsen
dc.date.accessioned2024-06-12T10:51:54Z
dc.date.available2024-06-12T10:51:54Z
dc.date.issued2007
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjectives: The present study was designed to determine the bacteria causing urinary tract infections (UTI) in our hospital and their susceptibility to various antibiotics. Study Design: Susceptibility of 259 uropathogen Escherichia Coli (E.Coli) isolates from urine samples of patients treated in the wards and intensive care units or in the outpatient clinics of our hospital between March 2004 and February 2005, to ampicillin, amoxycillin-clavulanate, gentamicin, ceftriaxone, ofloxacin, ciprofloxacin, co-trimoxazole, and naliclixic acid, the most commonly used antibiotics in UTI, Were evaluated. Among the isolated strains, 63 were from nosocomial and 196 were from community acquired UTI. Identification and susceptibility of strains were determined by an automatized VITEK-1 panel (Biomerieux, France). Results: Comparison of antibiotic susceptibility rates between nosocomial and community-acquired UTI revealed the following results: ampicillin 63-32%, amoxycillin-clavulanate 78-58%, gentamicin 89-83%, ceftriaxone 94-89%, ofloxacin 82-59%, ciprofloxacin 81-54%, cotrimoxazole 71-47%, naliclixic acid 86-64%, nosocomial and community-acquired UTI, respectively. Conclusion: In our opinion, for our region, ciprofloxacin would be the appropriate option for ampiric therapy in patients with probable community-acquired UTI and ampiric parenteral treatment with ceftriaxone would be the appropriate first option in patients with probable nosocomial UTI.en_US
dc.identifier.endpage11en_US
dc.identifier.issn1301-3149
dc.identifier.issue1en_US
dc.identifier.startpage6en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18522
dc.identifier.volume24en_US
dc.identifier.wosWOS:000257598600003en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.publisherEkin Tibbi Yayincilik Ltd Sti-Ekin Medical Publen_US
dc.relation.ispartofTrakya Universitesi Tip Fakultesi Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnti-Bacterial Agentsen_US
dc.subjectEscherichia Colien_US
dc.subjectUrinary Tract Infectionen_US
dc.subjectAntimicrobial Surveillance Programen_US
dc.subjectTract-Infectionsen_US
dc.subjectAntibiotic Susceptibilityen_US
dc.subjectHospitalized-Patientsen_US
dc.subjectResistanceen_US
dc.subjectPathogensen_US
dc.subjectTrendsen_US
dc.titleSusceptibility of escherichia coli strains isolated from urine cultures to some commonly used antibacterial agentsen_US
dc.typeArticleen_US

Dosyalar